コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sease characterized by the loss of upper and lower motor neurons.
2 terized by the progressive loss of upper and lower motor neurons.
3 (ALS) is a fatal disease affecting upper and lower motor neurons.
4 aracterized by progressive loss of upper and lower motor neurons.
5 uscular disease characterized by the loss of lower motor neurons.
6 of injuries affecting the spinal cord or the lower motor neurons.
7 length-dependent axonal degeneration of the lower motor neurons.
8 roup of pathologies that affect upper and/or lower motor neurons.
9 acterized by early onset and degeneration of lower motor neurons.
10 w levels of SMN protein, primarily affecting lower motor neurons.
11 by muscular atrophy due to loss of upper and lower motor neurons.
12 rophy (SBMA) that leads to selective loss of lower motor neurons.
13 recessive disorder characterized by loss of lower motor neurons.
14 disease caused by degeneration of upper and lower motor neurons.
15 axonopathies affecting peripheral nerves and lower motor neurons.
16 ong CNS pathway comprising corticospinal and lower motor neurons.
17 ve disease that mainly affects the upper and lower motor neurons.
18 or muscle in non-cell autonomous toxicity of lower motor neurons.
21 n = 3 SOD1 I113T mutation carriers, diffuse lower motor neuron and upper motor neuron signs evolved
22 characterized by the death of both upper and lower motor neurons and by 3- to 5-yr median survival po
25 to the progressive degeneration of upper and lower motor neurons and of neocortical areas, respective
26 his neuromuscular disorder which affects the lower motor neurons and proximal muscles of the limbs an
27 f mutant human SOD1 mRNA levels in upper and lower motor neurons and significant improvements in mult
28 nction (NMJ) is the unique interface between lower motor neurons and skeletal muscle fibers and is in
29 (SMN1) causes the selective degeneration of lower motor neurons and subsequent atrophy of proximal s
30 , SMA pathology was thought to be limited to lower motor neurons and the skeletal muscles they contro
31 ce of any detectable degenerative changes in lower motor neurons and with a molecular profile distinc
32 en in the neuromuscular junctions (NMJs) and lower motor neurons, and selective reduction of toxic mu
33 ve spinal muscular atrophy has revealed that lower motor neurons appear to have a specific vulnerabil
36 ly progressive neurodegenerative pathways in lower motor neurons around the time of disease onset rat
37 identified a defect in repetitive firing of lower motor neurons as a novel contributor to intensive
40 uitously expressed gene (SMN1), with loss of lower motor neurons being the primary pathological signa
41 ive disease that primarily affects upper and lower motor neurons, but also frontotemporal and other r
42 ed SMN protein result in the degeneration of lower motor neurons, but it remains unclear whether othe
43 Kennedy disease, a degenerative disorder of lower motor neurons caused by a CAG/glutamine expansion
44 s and post-synaptic motor endplates, loss of lower motor neuron cell bodies and denervation of neurom
45 ting neurological disease marked by isolated lower motor neuron death and subsequent atrophy of skele
46 enerative disease characterized by upper and lower motor neuron death with ascending paralysis leadin
48 ease and all cases showed combined upper and lower motor neuron degeneration (amyotrophic lateral scl
49 akness, with signs and symptoms of upper and lower motor neuron degeneration in multiple myotomes, wi
50 gical analyses indicated a similar extent of lower motor neuron degeneration in SODMutM maintained on
51 tion of needle electromyographic evidence of lower motor neuron degeneration into diagnostic criteria
52 was degeneration of the motor cortex without lower motor neuron degeneration or involvement of other
53 cterized as exhibiting adult-onset upper and lower motor neuron degeneration, but closer examination
54 ult-onset disease characterized by upper and lower motor neuron degeneration, muscle wasting and para
55 that is characterized by selective upper and lower motor neuron degeneration, the pathogenesis of whi
61 sive and heterogeneous group of upper and/or lower motor neuron degenerative disorders, in which the
63 A) is a fully penetrant, autosomal recessive lower motor neuron disease in domestic cats that clinica
65 any forms of spinal muscular atrophy, a pure lower motor neuron disease, have been characterized clin
66 loss-of-function of HSJ1 is linked to a pure lower motor neuron disease, strongly suggesting that HSJ
70 clerosis (ALS) is characterized by upper and lower motor neuron dysfunction and loss, rapidly progres
71 of neuromuscular disorders characterized by lower motor neuron dysfunction, slowly progressive lengt
74 or pathological hallmark of SMA is a loss of lower motor neurons from spinal cord and peripheral nerv
75 to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP)
78 ite the vulnerability of these spinal axons, lower motor neurons in ALS2-deficient mice were preserve
79 disease (PD), the degeneration of upper and lower motor neurons in amyotrophic lateral sclerosis (AL
82 ent plasticity of synapses between upper and lower motor neurons in the spinal cord, downstream of su
87 utput and selectively degenerate (along with lower motor neurons) in amyotrophic lateral sclerosis.
89 disrupt prenatal developmental processes in lower motor neurons, influencing neuronal outgrowth, axo
91 new technologies sensitive to both upper and lower motor neuron involvement may ultimately resolve co
92 phenotype with a mixed picture of upper and lower motor neuron involvement reminiscent of amyotrophi
93 l sclerosis that acknowledged both upper and lower motor neuron involvement was attributed to Jean-Ma
94 nversion, namely NfL levels, depression, and lower motor neuron involvement, differ from those drivin
95 equiring dinical evidence for both upper and lower motor neuron involvement, should be modified; ie,
98 m cell (iPSC)-induced excitatory neurons and lower motor neurons, iPSC-derived hippocampal dentate gy
100 aracterized by the selective degeneration of lower motor neurons, leading to muscle atrophy and, in t
102 adily established, functional assessments of lower motor neuron (LMN) innervation of forelimb muscles
103 aired body region attribute to impairment of lower motor neuron (LMN) or UMN or mixed LMN and UMN?
106 d white matter tract damage in patients with lower motor neuron (LMN)-predominant disease compared wi
108 and/or progressive degeneration of upper and lower motor neurons (LMNs) causes neurological symptoms
115 Spinal muscular atrophy is a disorder of lower motor neurons, most commonly caused by recessive m
116 plex and not related simply to the degree of lower motor neuron muscle wasting but, rather, depend on
117 Mutant TDP-43-dependent degeneration of lower motor neurons occurs without: (i) loss of TDP-43 f
119 ilhier) had already recognized a progressive lower motor neuron-only syndrome within a broader, clini
120 ease progression, and in ALS patient-derived lower motor neurons, our AAV vector transduced >95% of c
123 tive disorder in which the loss of upper and lower motor neurons produces progressive weakness and ev
125 s characterized by degeneration of upper and lower motor neurons, resulting in progressive weakness a
128 for definite, probable, or possible ALS with lower motor neuron signs by modified El Escorial Criteri
130 related to the balance of clinical upper and lower motor neuron signs, upper versus lower limb onset
133 disease characterized by combined upper and lower motor neuron symptoms and signs with onset prior t
136 odal antigens as novel autoimmune targets in lower motor neuron syndrome provide new insights into th
137 woman with breast cancer and paraneoplastic lower motor neuron syndrome whose serum contained autoan
140 A)) receptors in their CNS, particularly the lower motor neurons, than do wild-type mice, indicating
141 to rescue or replace degenerating upper and lower motor neurons through endogenous recruitment or au
144 clerosis (ALS) is a disease of the upper and lower motor neurons, to date none of the compounds in cl
146 ated neurofilaments (NP-NF) in the upper and lower motor neurons was investigated in the rat, the com
147 a neurodegenerative disease of the upper and lower motor neurons with varying ages of onset, progress
148 aracterized by progressive loss of upper and lower motor neurons, with a median survival of 2-3 years
149 almost exclusively as a disease of upper and lower motor neurons, with muscle changes interpreted as
150 l process that preferentially affects lumbar lower motor neurons, with or without additional upper mo
151 aracterized by the degeneration of upper and lower motor neurons within the brain and spinal cord.